O	O	0	2	An	An	B-NP	DT	O	3	NMOD	O
O	O	3	12	essential	essential	I-NP	JJ	O	3	NMOD	O
O	O	13	17	role	role	I-NP	NN	O	0	ROOT	O
O	O	18	21	for	for	B-PP	IN	O	3	NMOD	O
T8	B-Entity	22	24	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T8	I-Entity	24	25	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T8	I-Entity	25	31	kappaB	kappaB	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	32	34	in	in	B-PP	IN	O	3	NMOD	O
O	O	35	40	human	human	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
T1	B-Protein	41	45	CD34	CD34	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	45	46	(	(	O	(	I-cell_type	13	DEP	I-cell_type
O	O	46	47	+	+	O	SYM	I-cell_type	13	DEP	I-cell_type
O	O	47	48	)	)	O	)	I-cell_type	17	NMOD	I-cell_type
O	O	49	53	bone	bone	B-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	54	60	marrow	marrow	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	61	65	cell	cell	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	66	74	survival	survival	I-NP	NN	O	8	PMOD	O
O	O	74	75	.	.	O	.	O	3	P	O

O	O	77	80	The	The	B-NP	DT	O	3	NMOD	O
O	O	81	94	transcription	transcription	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	95	101	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	101	102	,	,	O	,	O	7	P	O
T9	B-Entity	103	105	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T9	I-Entity	105	106	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T9	I-Entity	106	112	kappaB	kappaB	I-NP	NN	I-protein	9	SUB	I-protein
O	O	112	113	,	,	O	,	O	7	P	O
O	O	114	116	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	117	126	important	important	B-ADJP	JJ	O	9	PRD	O
O	O	127	130	for	for	B-PP	IN	O	10	AMOD	O
O	O	131	132	T	T	B-NP	NN	O	15	NMOD	O
O	O	132	133	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	133	137	cell	cell	I-NP	NN	O	15	NMOD	O
O	O	138	148	activation	activation	I-NP	NN	O	26	NMOD	O
O	O	148	149	,	,	O	,	O	26	P	O
O	O	150	151	B	B	B-NP	NN	O	20	NMOD	O
O	O	151	152	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	152	156	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	157	167	maturation	maturation	I-NP	NN	O	26	NMOD	O
O	O	167	168	,	,	O	,	O	26	P	O
O	O	169	172	and	and	O	CC	O	26	NMOD	O
O	O	173	178	human	human	B-NP	JJ	O	26	NMOD	O
O	O	179	195	immunodeficiency	immunodeficiency	I-NP	NN	O	26	NMOD	O
O	O	196	201	virus	virus	I-NP	NN	O	26	NMOD	O
O	O	202	215	transcription	transcription	I-NP	NN	O	11	PMOD	O
O	O	216	219	and	and	O	CC	O	9	VMOD	O
O	O	220	225	plays	play	B-VP	VBZ	O	9	VMOD	O
O	O	226	227	a	a	B-NP	DT	O	30	NMOD	O
O	O	228	232	role	role	I-NP	NN	O	28	OBJ	O
O	O	233	235	in	in	B-PP	IN	O	28	VMOD	O
O	O	236	249	alternatively	alternatively	B-VP	RB	O	33	VMOD	O
O	O	250	259	mediating	mediate	I-VP	VBG	O	35	VMOD	O
O	O	260	263	and	and	I-VP	CC	O	35	VMOD	O
O	O	264	274	protecting	protect	I-VP	VBG	O	31	PMOD	O
O	O	275	282	against	against	B-PP	IN	O	35	VMOD	O
O	O	283	292	apoptosis	apoptosis	B-NP	NN	O	36	PMOD	O
O	O	293	295	in	in	B-PP	IN	O	35	VMOD	O
O	O	296	297	a	a	B-NP	DT	O	40	NMOD	O
O	O	298	305	variety	variety	I-NP	NN	O	38	PMOD	O
O	O	306	308	of	of	B-PP	IN	O	40	NMOD	O
O	O	309	313	cell	cell	B-NP	NN	O	43	NMOD	O
O	O	314	319	types	type	I-NP	NNS	O	41	PMOD	O
O	O	319	320	.	.	O	.	O	9	P	O

O	O	321	328	However	However	B-ADVP	RB	O	18	VMOD	O
O	O	328	329	,	,	O	,	O	18	P	O
O	O	330	331	a	a	B-NP	DT	O	4	NMOD	O
O	O	332	336	role	role	I-NP	NN	O	18	SUB	O
O	O	337	340	for	for	B-PP	IN	O	4	NMOD	O
T10	B-Entity	341	343	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T10	I-Entity	343	344	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T10	I-Entity	344	350	kappaB	kappaB	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	351	353	in	in	B-PP	IN	O	4	NMOD	O
O	O	354	359	human	human	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
T2	B-Protein	360	364	CD34	CD34	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	364	365	(	(	O	(	I-cell_type	14	DEP	I-cell_type
O	O	365	366	+	+	O	SYM	I-cell_type	14	DEP	I-cell_type
O	O	366	367	)	)	O	)	I-cell_type	11	NMOD	I-cell_type
O	O	368	372	bone	bone	B-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	373	379	marrow	marrow	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	380	385	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	386	389	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	390	393	not	not	I-VP	RB	O	18	VMOD	O
O	O	394	398	been	be	I-VP	VBN	O	18	VC	O
O	O	399	408	described	describe	I-VP	VBN	O	20	VC	O
O	O	408	409	.	.	O	.	O	18	P	O

O	O	410	412	We	We	B-NP	PRP	O	2	SUB	O
O	O	413	420	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	421	429	evidence	evidence	B-NP	NN	O	2	OBJ	O
O	O	430	434	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	435	439	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	440	449	virtually	virtually	B-NP	RB	O	15	NMOD	O
O	O	450	453	all	all	I-NP	DT	O	15	NMOD	O
O	O	454	459	human	human	I-NP	JJ	B-cell_type	15	NMOD	B-cell_type
T3	B-Protein	460	464	CD34	CD34	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	464	465	(	(	O	(	I-cell_type	12	DEP	I-cell_type
O	O	465	466	+	+	O	SYM	I-cell_type	12	DEP	I-cell_type
O	O	466	467	)	)	O	)	I-cell_type	9	NMOD	I-cell_type
O	O	468	472	bone	bone	B-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	473	479	marrow	marrow	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	480	485	cells	cell	I-NP	NNS	I-cell_type	16	SUB	I-cell_type
O	O	486	493	express	express	B-VP	VBP	O	5	SBAR	O
T11	B-Entity	494	496	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T11	I-Entity	496	497	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T11	I-Entity	497	503	kappaB	kappaB	I-NP	NN	I-protein	16	OBJ	I-protein
O	O	504	508	that	that	B-NP	WDT	O	19	NMOD	O
O	O	509	512	can	can	B-VP	MD	O	20	SBAR	O
O	O	513	515	be	be	I-VP	VB	O	21	VC	O
O	O	516	525	activated	activate	I-VP	VBN	O	22	VC	O
O	O	526	528	by	by	B-PP	IN	O	23	VMOD	O
O	O	529	537	exposure	exposure	B-NP	NN	O	36	NMOD	O
O	O	538	540	to	to	B-PP	TO	O	25	NMOD	O
O	O	541	548	phorbol	phorbol	B-NP	NN	O	33	NMOD	O
O	O	549	551	12	12	I-NP	CD	O	27	NMOD	O
O	O	551	552	-	-	O	HYPH	O	33	NMOD	O
O	O	552	561	myristate	myristate	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	562	564	13	13	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	564	565	-	-	I-NP	HYPH	O	30	P	O
O	O	565	572	acetate	acetate	I-NP	NN	O	26	PMOD	O
O	O	573	576	and	and	O	CC	O	36	NMOD	O
O	O	577	578	a	a	B-NP	DT	O	36	NMOD	O
O	O	579	586	variety	variety	I-NP	NN	O	58	NMOD	O
O	O	587	589	of	of	B-PP	IN	O	36	NMOD	O
O	O	590	599	cytokines	cytokine	B-NP	NNS	B-protein	37	PMOD	B-protein
O	O	599	600	,	,	O	,	O	36	P	O
O	O	601	603	eg	eg	B-NP	FW	O	58	NMOD	O
O	O	603	604	,	,	O	,	O	40	P	O
T4	B-Protein	605	610	tumor	tumor	B-NP	NN	B-protein	45	NMOD	B-protein
T4	I-Protein	611	619	necrosis	necrosis	I-NP	NN	I-protein	45	NMOD	I-protein
T4	I-Protein	620	626	factor	factor	I-NP	NN	I-protein	45	NMOD	I-protein
T4	I-Protein	627	632	alpha	alpha	I-NP	NN	I-protein	58	NMOD	I-protein
O	O	632	633	,	,	O	,	O	58	P	O
T5	B-Protein	634	645	interleukin	interleukin	B-NP	NN	B-protein	48	NMOD	B-protein
T5	I-Protein	645	646	-	-	B-NP	HYPH	I-protein	58	NMOD	I-protein
T5	I-Protein	646	647	3	3	I-NP	CD	I-protein	48	NMOD	I-protein
O	O	647	648	,	,	O	,	O	58	P	O
O	O	649	652	and	and	O	CC	O	58	NMOD	O
T6	B-Protein	653	664	granulocyte	granulocyte	B-NP	NN	B-protein	58	NMOD	B-protein
T6	I-Protein	664	665	-	-	O	HYPH	I-protein	58	NMOD	I-protein
T6	I-Protein	665	675	macrophage	macrophage	B-NP	NN	I-protein	58	NMOD	I-protein
T6	I-Protein	676	682	colony	colony	I-NP	NN	I-protein	58	NMOD	I-protein
T6	I-Protein	682	683	-	-	O	HYPH	I-protein	58	NMOD	I-protein
T6	I-Protein	683	694	stimulating	stimulate	B-VP	VBG	I-protein	58	NMOD	I-protein
T6	I-Protein	695	701	factor	factor	B-NP	NN	I-protein	24	PMOD	I-protein
O	O	701	702	.	.	O	.	O	2	P	O

O	O	703	705	In	In	B-PP	IN	O	5	VMOD	O
O	O	706	714	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	714	715	,	,	O	,	O	5	P	O
O	O	716	718	we	we	B-NP	PRP	O	5	SUB	O
O	O	719	730	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	731	735	that	that	B-SBAR	IN	O	5	VMOD	O
T12	B-Entity	736	738	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T12	I-Entity	738	739	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T12	I-Entity	739	745	kappaB	kappaB	I-NP	NN	I-protein	10	SUB	I-protein
O	O	746	749	may	may	B-VP	MD	O	6	SBAR	O
O	O	750	752	be	be	I-VP	VB	O	10	VC	O
O	O	753	761	required	require	I-VP	VBN	O	11	VC	O
O	O	762	765	for	for	B-PP	IN	O	12	VMOD	O
O	O	766	771	human	human	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
T7	B-Protein	772	776	CD34	CD34	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	776	777	(	(	O	(	I-cell_type	18	DEP	I-cell_type
O	O	777	778	+	+	O	SYM	I-cell_type	18	DEP	I-cell_type
O	O	778	779	)	)	O	)	I-cell_type	23	NMOD	I-cell_type
O	O	780	784	bone	bone	B-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	785	791	marrow	marrow	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	792	796	cell	cell	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	797	807	clonogenic	clonogenic	I-NP	JJ	O	23	NMOD	O
O	O	808	816	function	function	I-NP	NN	O	25	NMOD	O
O	O	817	820	and	and	I-NP	CC	O	25	NMOD	O
O	O	821	829	survival	survival	I-NP	NN	O	13	PMOD	O
O	O	829	830	.	.	O	.	O	5	P	O

O	O	831	836	These	These	B-NP	DT	O	2	NMOD	O
O	O	837	844	results	result	I-NP	NNS	O	3	SUB	O
O	O	845	850	offer	offer	B-VP	VBP	O	0	ROOT	O
O	O	851	858	insight	insight	B-NP	NN	O	3	OBJ	O
O	O	859	863	into	into	B-PP	IN	O	4	NMOD	O
O	O	864	865	a	a	B-NP	DT	O	8	NMOD	O
O	O	866	869	new	new	I-NP	JJ	O	8	NMOD	O
O	O	870	874	role	role	I-NP	NN	O	5	PMOD	O
O	O	875	878	for	for	B-PP	IN	O	8	NMOD	O
T13	B-Entity	879	881	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T13	I-Entity	881	882	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T13	I-Entity	882	888	kappaB	kappaB	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	889	891	in	in	B-PP	IN	O	8	NMOD	O
O	O	892	903	maintaining	maintain	B-VP	VBG	O	13	PMOD	O
O	O	904	912	survival	survival	B-NP	NN	O	17	NMOD	O
O	O	913	916	and	and	I-NP	CC	O	17	NMOD	O
O	O	917	925	function	function	I-NP	NN	O	14	OBJ	O
O	O	926	928	in	in	B-PP	IN	O	14	VMOD	O
O	O	929	942	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	20	NMOD	B-cell_type
O	O	943	947	stem	stem	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	948	951	and	and	I-NP	CC	I-cell_type	23	NMOD	I-cell_type
O	O	952	962	progenitor	progenitor	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	963	968	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	969	972	and	and	O	CC	O	3	VMOD	O
O	O	973	980	suggest	suggest	B-VP	VBP	O	3	VMOD	O
O	O	981	985	that	that	B-SBAR	IN	O	25	VMOD	O
O	O	986	994	proposed	propose	B-NP	VBN	O	28	NMOD	O
O	O	995	1005	strategies	strategy	I-NP	NNS	O	42	SUB	O
O	O	1006	1015	involving	involve	B-VP	VBG	O	28	NMOD	O
O	O	1016	1026	inhibition	inhibition	B-NP	NN	O	29	OBJ	O
O	O	1027	1029	of	of	B-PP	IN	O	30	NMOD	O
T14	B-Entity	1030	1032	NF	NF	B-NP	NN	B-protein	34	NMOD	B-protein
T14	I-Entity	1032	1033	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T14	I-Entity	1033	1039	kappaB	kappaB	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	1040	1050	activation	activation	I-NP	NN	O	31	PMOD	O
O	O	1051	1053	as	as	B-PP	IN	O	28	NMOD	O
O	O	1054	1056	an	an	B-NP	DT	O	38	NMOD	O
O	O	1057	1064	adjunct	adjunct	I-NP	NN	O	36	PMOD	O
O	O	1065	1067	to	to	B-PP	TO	O	38	NMOD	O
O	O	1068	1074	cancer	cancer	B-NP	NN	O	41	NMOD	O
O	O	1075	1087	chemotherapy	chemotherapy	I-NP	NN	O	39	PMOD	O
O	O	1088	1094	should	should	B-VP	MD	O	26	SBAR	O
O	O	1095	1097	be	be	I-VP	VB	O	42	VC	O
O	O	1098	1108	approached	approach	I-VP	VBN	O	43	VC	O
O	O	1109	1113	with	with	B-PP	IN	O	44	VMOD	O
O	O	1114	1121	caution	caution	B-NP	NN	O	45	PMOD	O
O	O	1121	1122	.	.	O	.	O	3	P	O
